Medication info
Pitarotin 2 mg (Pitavastatin Calcium)

Pitarotin 2 mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201603044 · Approved 2016.05.30 · Insurance code 693902290

Summary

Main use
Improvement of mixed dyslipidemia and primary hypercholesterolemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of mixed dyslipidemia and primary hypercholesterolemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication is used to improve blood lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It helps to particularly lower total cholesterol, LDL-cholesterol, apo-B protein, and triglyceride levels, and increase levels of HDL-cholesterol, which is the good cholesterol. When used in conjunction with a diet, it can effectively regulate blood lipid imbalance, thus having a positive effect on the treatment of hyperlipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For example, patients with allergies to the ingredients of this drug or with liver dysfunction, severe liver disease or bile duct obstruction, those taking cyclosporine, those with myopathy, women who are pregnant or may become pregnant, nursing mothers, and children should not receive this medication. In addition, patients with impaired kidney function or a history of liver disease, those who consume alcohol excessively, patients with hypothyroidism, elderly patients, and those with muscle weakness should use this medication with caution. While taking this medication, various side effects such as muscle pain, weakness, liver dysfunction, thrombocytopenia, and allergic reactions may occur, and if symptoms appear, consultation with a physician should be sought immediately. In particular, serious muscle disease known as rhabdomyolysis may occur rarely, hence if muscle pain or weakness is experienced, administration should be suspended immediately. Regular liver function tests are required, and if liver enzyme levels rise, treatment should be discontinued and appropriate measures taken. This medication may interact with other drugs, especially if taken with cyclosporine or fibrates, niacin, or erythromycin, as this may increase the risk of renal function deterioration and muscle damage, therefore co-administration should be avoided or used with caution. Elderly patients may experience side effects more readily when taking this medication, thus dosage adjustment and caution are necessary. Pregnant or nursing women should not take this medication, and if pregnancy is confirmed, administration should be discontinued immediately. Finally, the safety and efficacy of this medication have not been established in children, hence it should not be used in pediatric patients. Lastly, this medication should be kept out of the reach of children and stored in its original container to prevent misuse or deterioration in quality.

Side effects

  • Abdominal pain
  • rash
  • lethargy
  • paralysis
  • itching
  • muscle pain
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 77 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • hives
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • feeling of weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • joint pain
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • increased uric acid levels
  • elevated serum potassium and phosphorus
  • taste abnormalities
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • skin numbness
  • loss of appetite
  • elevated blood pressure
  • discomfort in the chest
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that blocks light and air, at room temperature between 1 to 30 degrees Celsius. Proper storage helps to maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.